Furthermore, in chronic hepatitis, it was found that the deletion of p53-negative regulator MDM2 led to sustained p53 activation, inducing hepatocyte apoptosis and an increase in the senescence-associated secretory phenotype, leading to inflammation and accelerated hepatocarcinogenesis [61]. Here, TP53 is linked to chronic hepatitis.